Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « ISSN » - entrée « 0264-410X »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0262-0898 < 0264-410X < 0264-6021  Facettes :

List of bibliographic references indexed by 0264-410X

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
001519 (2009) Carolyn Saylor [États-Unis] ; Ekaterina Dadachova [États-Unis] ; Arturo Casadevall [États-Unis]Monoclonal antibody-based therapies for microbial diseases
001565 (2009) W. Huisman [Pays-Bas] ; B. E. E. Martina [Pays-Bas] ; G. F. Rimmelzwaan [Pays-Bas] ; R. A. Gruters [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas]Vaccine-induced enhancement of viral infections
001687 (2007) Masaji Okada [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Yoko Kita [Japon] ; Noriko Kanamaru [Japon] ; Yasuko Nishida [Japon] ; Yoshie Tsunai [Japon] ; Ruriko Inoue [Japon] ; Hitoshi Nakatani [Japon] ; Reiko Fukamizu [Japon] ; Yumi Namie [Japon] ; Junko Yamada [Japon] ; Kyoko Takao [Japon] ; Ritsuko Asai [Japon] ; Ryoko Asaki [Japon] ; Tetsuo Kase [Japon] ; Yuji Takemoto [Japon] ; Shigeto Yoshida [Japon] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
001764 (2005) Dinesh S. Bangari ; Suresh K. MittalDevelopment of nonhuman adenoviruses as vaccine vectors
001786 (2005) Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
001937 (1999) Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis]Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1
001960 (1998) F. M. Fernandez [États-Unis, Argentine] ; M. E. Conner [États-Unis] ; D. C. Hodgins [États-Unis] ; A. V. Parwani [États-Unis] ; P. R. Nielsen [États-Unis] ; S. E. Crawford [Argentine] ; M. K. Estes [Argentine] ; L. J. Saif [États-Unis]Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines
001983 (1997) Terecita D. Yule [États-Unis] ; Mark B. Roth [États-Unis] ; Kimberly Dreier [États-Unis] ; Anthony F. Johnson [États-Unis] ; Melissa Palmer-Densmore [États-Unis] ; Kris Simmons [États-Unis] ; Robert Fanton [États-Unis]Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease
001A27 (1995) Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector
001A28 (1995) Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease
001A29 (1995) New epitope-bearing portions of Entamoeba histolytica ; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine
001A31 (1995) Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine
001A83 (1993) Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy
001A87 (1993) Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle
001A89 (1993) Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis
001A92 (1993) New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production
001A93 (1993) Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine
001B31 (1992) Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
001B32 (1992) Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1
001B37 (1992) Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus
001B38 (1992) Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0264-410X" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0264-410X" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0264-410X
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021